Articles & Issues

Cover Image

3rd Special Issue: Pharmacoeconomics and Outcomes Research in Asia

Search Within This Issue

30 Articles:

  • 1
Article Title Author(s) Pages
Editorial Board

IFC
Sponsorship
Article Title Author(s) Pages
3rd Special Issue: Pharmacoeconomics & Outcomes Research in Asia

i
Table of Contents

ii-iii
Copyright/Subscription

iv
Editorial
Article Title Author(s) Pages
Bridging the Gap in Pharmacoeconomics and Outcomes Research between Researchers, Policymakers, and Practitioners in the Asia-Pacific Region

Vithaya Kulsomboon, Bong-min Yang, Shanlian Hu S1-S2
Economic Evaluation
Article Title Author(s) Pages
Cost-Effectiveness Analysis for Antidepressants and Cognitive Behavioral Therapy for Major Depression in Thailand

Benjamas Prukkanone, Theo Vos, Melanie Bertram, Stephen Lim S3-S8
The Effects of Medication Supply on Hospitalizations and Health-Care Costs in Patients with Chronic Heart Failure

Piyemeth Dilokthornsakul, Nathorn Chaiyakunapruk, Piyarat Nimpitakpong, Napawan Jeanpeerapong, Rosarin Sruamsiri et al. S9-S14
Cost-Effectiveness Analysis of Pneumococcal Conjugate Vaccine in Taiwan: A Transmission Dynamic Modeling Approach

David Bin-Chia Wu, Chee-Jen Chang, Yu-Chering Huang, Yu-Wen Wen, Chia-Ling Wu, Cathy Shen-Jang Fann et al. S15-S19
Evidence to Inform Decision Makers in Thailand: A Cost-Effectiveness Analysis of Screening and Treatment Strategies for Postmenopausal Osteoporosis

Pritaporn Kingkaew, Usawadee Maleewong, Chardpraorn Ngarmukos, Yot Teerawattananon S20-S28
Cost and Effectiveness Evaluation of Prophylactic HPV Vaccine in Developing Countries

Wichai Termrungruanglert, Piyalamporn Havanond, Nipon Khemapech, Somrat Lertmaharit, Sathirakorn Pongpanich, Chonlakiet Khorprasert, Surasak Taneepanichskul et al. S29-S34
Availability, Health-Care Costs, and Utilization Patterns of Biologics in Taiwan

Chee-Ruey Hsieh, Ya-Ming Liu S35-S42
Cost of Illness and Quality of Life of Patients with Rheumatoid Arthritis in South Korea

Tae-Jin Lee, Bo Hyun Park, Hye Kyung Son, Ran Song, Ki Chul Shin, Eun Bong Lee, Yeong-Wook Song et al. S43-S49
Cost-Effectiveness of Various Tuberculosis Control Strategies in Thailand

Pojjana Hunchangsith, Jan J. Barendregt, Theo Vos, Melanie Bertram S50-S55
Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting: A Health Economic Model Based on the PREDICTIVE Study

Li Yang, Torsten Christensen, Fengyu Sun, Jinghua Chang S56-S59
Patient-Reported Outcomes
Article Title Author(s) Pages
A Multilevel Analysis of Regional and Individual Effects on Methadone Maintenance Treatment in Taiwan

Chia-Yu Chen, Shuo-Yen Ting, Happy Kuy-Lok Tan, Ming-Chin Yang S60-S64
The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan

Gordon G. Liu, Marco daCosta DiBonaventura, Yong Yuan, Jan-Samuel Wagner, Gilbert J. L'Italien, Paul Langley, Isao Kamae et al. S65-S71
An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore

Xu-Hao Zhang, Shu-Chuen Li, Feng Xie, Ngai-Nung Lo, Kwang-Ying Yang, Seng-Jin Yeo, Kok-Yong Fong, Julian Thumboo et al. S72-S78
Health Utility Measured with EQ-5D in Thai Patients Undergoing Peritoneal Dialysis

Phantipa Sakthong, Vijj Kasemsup S79-S84
Preference-Based Assessment
Article Title Author(s) Pages
Estimating an EQ-5D Value Set for Malaysia Using Time Trade-Off and Visual Analogue Scale Methods

Faridah Aryani Md Yusof, Adrian Goh, Soraya Azmi S85-S90
Health Policy Analysis
Article Title Author(s) Pages
Eliciting Public Preference for Health-Care Resource Allocation in South Korea

Min Kyoung Lim, Eun Young Bae, Sang-Eun Choi, Eui Kyung Lee, Tae-Jin Lee et al. S91-S94
Impact of the Introduction of Government Use Licenses on the Drug Expenditure on Seven Medicines in Thailand

Adun Mohara, Inthira Yamabhai, Kakanang Chaisiri, Sripen Tantivess, Yot Teerawattananon et al. S95-S99
Different Policy Outcomes of the New Drugs and Currently Listed Drugs under the Positive List System in South Korea

Eui-Kyung Lee, Bo-Yeon Kim, Jae-Young Lim, Mi-Hai Park S100-S103
Assessment of Pharmacoeconomic Evaluations Submitted for Reimbursement in Korea

Eun-Young Yim, Sang Hee Lim, Mi-Jeong Oh, Hye Kyung Park, Ji-Ryoun Gong, Sung Eun Park, So Young Yi et al. S104-S110
Successful Implementation of a P&T-Approved Therapeutic Interchange Program of Angiotensin II Receptor Blockers in a Medical Center in Taiwan

Yen-Ying Lee, Paul Hsiao, You-Meei Lin, Yu-Hsuan Yen, Hsiang-Yin Chen et al. S111-S115
Antibiotic-Prescribing Practices of Primary Care Prescribers for Acute Diarrhea in New Delhi, India

Anita Kotwani, Ranjit Roy Chaudhury, Kathleen Holloway S116-S119
Decision-Maker Commentary
Article Title Author(s) Pages
Drug Reimbursement Decision-Making in Thailand, China, and South Korea

Surachat Ngorsuraches, Wei Meng, Bo-Yeon Kim, Vithaya Kulsomboon S120-S125
National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

Worasuda Yoongthong, Shanlian Hu, Jennifer A. Whitty, Suwit Wibulpolprasert, Kitti Sukantho, Wannisa Thienthawee, Huixue Han, Paul A. Scuffham et al. S126-S131
Health-Care Data Collecting, Sharing, and Using in Thailand, China Mainland, South Korea, Taiwan, Japan, and Malaysia

Syed Mohamed Aljunid, Samrit Srithamrongsawat, Wen Chen, Seung Jin Bae, Raoh-Fang Pwu, Shunya Ikeda, Ling Xu et al. S132-S138
Acknowledgments
Article Title Author(s) Pages
Reviewer Acknowledgement

S139-S142
Instructions for Authors

I-II

30 Articles:

  • 1